Nosis Bioscience

Company facts

• Founded

  2021

  ReportedSource for founded (opens in new tab)

• Headquarters

  United States (San Francisco Bay Area, CA)

  ReportedSource for headquarters (opens in new tab)

• Total funding

  $13M

  ReportedSource for total funding (opens in new tab)

Latest funding round

Drug discovery partners

3 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

• Johnson & Johnson Pharma

  Collaboration and license expanded to neurology, Mar 2026

  Terms not disclosed

  ConfirmedSource for Johnson & Johnson (opens in new tab)

• Daiichi Sankyo Pharma

  Research collaboration and option, Mar 11, 2025

  Terms not disclosed

  ConfirmedSource for Daiichi Sankyo (opens in new tab)

• Daiichi Sankyo Pharma

  RNA delivery partnership, Mar 11, 2025

  Terms not disclosed

  ReportedSource for Daiichi Sankyo (opens in new tab)

Recent news

• Mar 2026

  Collaboration and license expanded to neurology with Johnson & Johnson

  ConfirmedSource (opens in new tab)

• Jul 31, 2025

  Nominates a development candidate for its lead fibrosis program

  ReportedSource (opens in new tab)

• Mar 12, 2025

  Daiichi Sankyo deal for AI-designed RNA delivery tech

  ReportedSource (opens in new tab)

• Mar 11, 2025

  Research collaboration and option agreement with Daiichi Sankyo on cell-targeted RNA medicines

  ConfirmedSource (opens in new tab)